Preclinical models are research tools used to test new treatments before trying them ... single behaviour is guaranteed to prevent dementia - but there's lots of evidence to suggest that making ...

A groundbreaking discovery by scientists at Japan’s RIKEN Center for Brain Science has revealed an unexpected link between dopamine and Alzheimer’s disease. This revelation could mark a major ...

Kathy Ingebrand was diagnosed with Alzheimer's at 59 years old. "This patient is receiving a treatment ... her insurance will cover the cost. There are possible side effects, Bazakos said ...

Ways to lower your risk of Alzheimer's There are things you can do to reduce ... "Targeting this pathway may open up new avenues for treatment by either halting the toxic lipid production or ...

"There is still no cure for Alzheimer's, and that's important to understand," Jing said. "But this treatment can help people maintain their independence and thinking skills longer and give people ...

Researchers linked cellular stress in the brain to the progression of Alzheimer’s. Picture: iStock This step is important to make sure that only the best and safest treatments are tested on ...

Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment ... efficacy or safety. There is no guarantee ...

when it had rejected the treatment by saying the risk of serious brain swelling did not outweigh its small impact on slowing cognitive decline. Alzheimer's is the most common cause of dementia and ...

Once there, the virus can change the immune system and contribute to other changes associated with Alzheimer's disease. This virus may be a target for antiviral treatments. Arizona State ...

(“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease ...

(This Dec. 17 story has been corrected to say that the EU regulator reversed its July decision in November to recommend approval for Biogen's drug, Leqembi, in paragraph 8) (Reuters) - China's medical ...